Prasol Chemicals’ initial public offering attracted strong retail participation on the second day of bidding, but its modest grey-market premium is keeping expectations for an early listing gain in check. The contrast between demand from individual investors and the muted unofficial premium is now the central business question around the Rs 500 crore issue.

Moneycontrol reported that the offer was subscribed 72% by 5:00 pm on September 9. Investors bid for 39,43,258 shares against 54,43,229 shares on offer, according to data from the National Stock Exchange. The retail portion was subscribed 1.14 times, while the non-institutional investor segment reached 66% subscription.

The Economic Times reported the same 72% overall subscription on Day 2 and said qualified institutional buyers remained largely on the sidelines. That split matters because an IPO can show visible retail interest without having broad participation across all investor groups. The subscription figures are a snapshot of bids received, not a guarantee that every application will receive an allotment.

Grey-market pricing offers a separate signal. Moneycontrol cited a premium of nearly 1% over the upper end of the price band on the morning of September 9. The Economic Times put the premium at Rs 30 a share, or about 4% over the upper price of Rs 676, with an implied price of around Rs 706. The figures are unofficial, unregulated and can change before listing, so they do not determine the final exchange price.

The issue has a price band of Rs 643 to Rs 676 per share and a lot size of 22 shares. At the upper end, the minimum retail application is Rs 14,872. The offer is scheduled to close on September 10, with allotment expected on September 11 and a tentative listing on the NSE and BSE on September 16, according to the Economic Times report.

Prasol’s fund-raising structure also gives investors a reason to look beyond the subscription headline. The IPO includes a fresh issue of Rs 80 crore and an offer for sale of up to Rs 420 crore. About Rs 60 crore from the proceeds is intended for repayment or prepayment of borrowings, with the balance earmarked for general corporate purposes. Because most of the issue is an offer for sale, the total money raised does not translate into an equal amount of new capital for the company.

The company manufactures speciality chemicals used in areas such as paints and inks, construction and adhesives, pharmaceuticals, agrochemicals, and personal care. The Economic Times said Prasol reported a 22% increase in total income to Rs 1,237.85 crore in FY26, while profit after tax rose 91% to Rs 83.12 crore. It operates facilities at Khopoli and Mahad, with a combined annual capacity of 98,644 tonnes, and served 1,600 customers as of July 31, 2026.

Those numbers point to a business with a broad customer and export base, but they do not remove operating risks. The Economic Times noted that unplanned shutdowns at manufacturing facilities could disrupt production. Investors also need to weigh the company’s valuation, debt-repayment plan and dependence on speciality-chemical demand against the limited listing premium currently indicated in the grey market.

Prasol Chemicals IPO demand is therefore sending two different messages. Retail bids show that the issue has captured attention, while the subdued Prasol Chemicals IPO GMP suggests the market is not pricing in a large immediate payoff. The final subscription mix, allotment data and the actual listing price will provide a more reliable test than unofficial premium estimates.